3/14
06:58 am
avbp
ArriVent BioPharma (AVBP) was upgraded by BTIG Research to "strong-buy".
Low
Report
ArriVent BioPharma (AVBP) was upgraded by BTIG Research to "strong-buy".
3/12
08:03 am
avbp
ArriVent BioPharma (AVBP) had its "buy" rating reaffirmed by BTIG Research. They now have a $42.00 price target on the stock.
Low
Report
ArriVent BioPharma (AVBP) had its "buy" rating reaffirmed by BTIG Research. They now have a $42.00 price target on the stock.
3/12
06:49 am
avbp
Rating for AVBP
Low
Report
Rating for AVBP
3/6
12:25 pm
avbp
ArriVent BioPharma (AVBP) had its "outperform" rating reaffirmed by Oppenheimer Holdings, Inc.. They now have a $50.00 price target on the stock, up from $44.00.
Medium
Report
ArriVent BioPharma (AVBP) had its "outperform" rating reaffirmed by Oppenheimer Holdings, Inc.. They now have a $50.00 price target on the stock, up from $44.00.
3/6
12:16 pm
avbp
Rating for AVBP
Medium
Report
Rating for AVBP
3/6
12:16 pm
avbp
Rating for AVBP
Medium
Report
Rating for AVBP
3/6
11:07 am
avbp
Rating for AVBP
Low
Report
Rating for AVBP
3/6
11:07 am
avbp
Rating for AVBP
Low
Report
Rating for AVBP
12/23
07:55 am
avbp
Rating for AVBP
Low
Report
Rating for AVBP
12/22
06:01 pm
avbp
ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Low
Report
ArriVent BioPharma (NASDAQ:AVBP) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
12/22
04:15 pm
avbp
ArriVent Biopharma initiated with an Overweight at Cantor Fitzgerald
Low
Report
ArriVent Biopharma initiated with an Overweight at Cantor Fitzgerald